Epidermal Growth Factor Receptor Inhibitor Database
|
|
|
|
|
|
|
|
|
|
|
| Experimental Information | |
| Enzymatic Activity | |
| Molecule Id | EGIN0004369 |
| PMID | 15711537 |
| Assay Used | Kinase assay |
| Experimently Validated | Yes |
| EGFR (IC50) | - |
| HER2 (IC50) | - |
| HER4 (IC50) | - |
| Mutant L858R (IC50) | - |
| Mutant T790M (IC50) | - |
| Double Mutant (IC50) | - |
| Average ERBB2 and ERBB1 (IC50) | - |
| Inhibition EGFR (%) | - |
| Inhibitory Concentration | - |
| Inhibition HER2 (%) | - |
| Inhibitory Concentration | - |
| Ki (EGFR) | - |
| Ki (HER2) | - |
| Ki (HER4) | - |
| Kd (EGFR) | 1.9 nM |
| Kd (L858R) | 0.81 nM |
| Kd (T790M) | - |
| Kd (L858R/T790M) | - |
| Kd (Other mutation) | 0.93 nM( L747-S752del P753S),1.3 nM( L747-E749del A750P),1.3 nM( L747-T751del insS),2.4 nM( L861Q),1.2 nM( G719C),1.3 nM( E746-A750del),0.78 nM( G719S),1.9 nM( S752-I759del) |
| Note | The paper presents A small molecule kinase interaction map for clinical kinase inhibitors |
| Extra | - |
| Cellular Activity | ||||||||||||||
| S.No. | Cell Line | Desp. | IC50 | IC80 | ED50 | GI50 | GI90 | EC50 | Kd | Inhibition (%) | Inhibitory Conc. | |||
| Activity against Receptor | |
| EGFR | Yes |
| HER2 | Yes |
| HER4 | - |
| Wild type | Yes |
| Mutant | L858R(Ka -value only) |
| Inhibitor Binding | |
| EGFR | - |
| HER2 | - |
| HER4 | - |